Suchergebnisse - "Cariou, Bertrand"

PubPharm (22)

1

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

enthalten in: Diabetes technology & therapeutics | 2019

von Danne, T. | Pettus, J. | Giaccari, A. | +9

2

Implementation of Basal-Bolus Therapy in Type 2 Diabetes : A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

enthalten in: Diabetes technology & therapeutics | 2019

von Bergenstal, R. | Peyrot, M. | Dreon, D. | +67

3

Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Buffet, A. | Ben Aim, L. | Leboulleux, S. | +31

4

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

enthalten in: Atherosclerosis | 2018

von Wargny, M. | Ducluzeau, P. | Petit, J. | +14

5

High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia : The French Familial Hypercholesterolemia Registry

enthalten in: Atherosclerosis | 2018

von Béliard, S. | Boccara, F. | Cariou, B. | +50

6

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes : The European inTandem2 Study

enthalten in: Diabetes care | 2018

von Danne, T. | Cariou, B. | Banks, P. | +9

7

Safety and convenience of once-weekly somapacitan in adult GH deficiency : a 26-week randomized, controlled trial

enthalten in: European journal of endocrinology | 2018

von Johannsson, G. | Feldt-Rasmussen, U. | Håkonsson, I. | +34

8

Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes

enthalten in: Diabetes care | 2018

von Bauduceau, B. | Le Floch, J. | Halimi, S. | +103

9

Alirocumab vs usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia : The ODYSSEY DM-DYSLIPIDEMIA randomized trial

enthalten in: Diabetes, obesity & metabolism | 2018

von Ray, K. | Leiter, L. | Müller-Wieland, D. | +9

10

Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial

enthalten in: Diabetes, obesity & metabolism | 2017

von Leiter, L. | Cariou, B. | Müller-Wieland, D. | +9

CommentIn: Ann Transl Med. 2018 Feb;6(3):60. - PMID 29610751